TokenPost topic

Agios Pharmaceuticals

1 TokenPost story is tagged Agios Pharmaceuticals. The newest appear first.

Latest Agios Pharmaceuticals stories

• FDA Extends Agios’ Mitapivat Review for Sickle Cell Disease by Three Months

  The updated PDUFA goal date is Feb. 1, 2027, moved from Nov. 1, 2026. The FDA accepted the application for Priority Review in July.

  Oct 30, 2026, 11:16 AM EDT · Regulation